A new drug could put an end to cumbersome CPAP machines, which are thought to be used by some 33 million Americans to manage their sleep apnea. Roughly 39 million Americans, including President Biden, ...
Sulthiame reduced breathing interruptions in sleep apnea patients, pointing toward a viable drug treatment. A European ...
Complications of sleep apnea can range from high blood pressure to heart problems and diabetes. But emerging research suggests that sleep apnea can sometimes trigger migraine episodes. Sleep apnea is ...
Share on Pinterest A clinical trial shows that Zepbound and Mounjaro reduced obstructive sleep apnea symptoms in people with obesity. NurPhoto/Getty Images Around 70% of people who have obstructive ...
As a young physician in Sydney, Australia in 1979, Colin Sullivan conceived of an experiment to help people with nighttime breathing issues. After several months of waiting for the right patient, he ...
A new survey reveals many Americans suffer from a potentially dangerous sleep disorder and aren't getting the treatment they need. March is National Sleep Month. Doctors say sleep apnea, when people ...
The weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea ...
If you have overweight or obesity, losing 5–10% of your body weight may help reduce or resolve sleep apnea symptoms. Obstructive sleep apnea is a common condition that can cause problems with your ...
Weight loss pills and injections are often touted as miracle drugs. Research shows that they can help you lose weight, better help you manage type II diabetes, and even reduce your risk of heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback